Literature DB >> 26839342

View from the heart: cardiac fibroblasts in development, scarring and regeneration.

Milena B Furtado1, Hieu T Nim2, Sarah E Boyd2, Nadia A Rosenthal3.   

Abstract

In the adult, tissue repair after injury is generally compromised by fibrosis, which maintains tissue integrity with scar formation but does not restore normal architecture and function. The process of regeneration is necessary to replace the scar and rebuild normal functioning tissue. Here, we address this problem in the context of heart disease, and discuss the origins and characteristics of cardiac fibroblasts, as well as the crucial role that they play in cardiac development and disease. We discuss the dual nature of cardiac fibroblasts, which can lead to scarring, pathological remodelling and functional deficit, but can also promote heart function in some contexts. Finally, we review current and proposed approaches whereby regeneration could be fostered by interventions that limit scar formation.
© 2016. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Fibroblasts; Heart; Regeneration; Scarring

Mesh:

Year:  2016        PMID: 26839342     DOI: 10.1242/dev.120576

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  57 in total

Review 1.  The epicardium as a hub for heart regeneration.

Authors:  Jingli Cao; Kenneth D Poss
Journal:  Nat Rev Cardiol       Date:  2018-10       Impact factor: 32.419

Review 2.  Fibroblasts and the extracellular matrix in right ventricular disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2017-10-01       Impact factor: 10.787

Review 3.  Cardiac fibroblasts: more than mechanical support.

Authors:  Stefanie A Doppler; Catarina Carvalho; Harald Lahm; Marcus-André Deutsch; Martina Dreßen; Nazan Puluca; Rüdiger Lange; Markus Krane
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 4.  Developmental origin and lineage plasticity of endogenous cardiac stem cells.

Authors:  Maria Paola Santini; Elvira Forte; Richard P Harvey; Jason C Kovacic
Journal:  Development       Date:  2016-04-15       Impact factor: 6.868

5.  SLIT3 deficiency attenuates pressure overload-induced cardiac fibrosis and remodeling.

Authors:  Lianghui Gong; Shuyun Wang; Li Shen; Catherine Liu; Mena Shenouda; Baolei Li; Xiaoxiao Liu; John A Shaw; Alan L Wineman; Yifeng Yang; Dingding Xiong; Anne Eichmann; Sylvia M Evans; Stephen J Weiss; Ming-Sing Si
Journal:  JCI Insight       Date:  2020-06-18

Review 6.  Human pluripotent stem cell-derived cardiac stromal cells and their applications in regenerative medicine.

Authors:  Martha E Floy; Taylor D Mateyka; Koji L Foreman; Sean P Palecek
Journal:  Stem Cell Res       Date:  2020-04-27       Impact factor: 2.020

7.  Reactivation of the Nkx2.5 cardiac enhancer after myocardial infarction does not presage myogenesis.

Authors:  Marcus-André Deutsch; Stefanie A Doppler; Xinghai Li; Harald Lahm; Gianluca Santamaria; Giovanni Cuda; Stefan Eichhorn; Thomas Ratschiller; Elda Dzilic; Martina Dreßen; Annekathrin Eckart; Konstantin Stark; Steffen Massberg; Anna Bartels; Christoph Rischpler; Ralf Gilsbach; Lutz Hein; Bernd K Fleischmann; Sean M Wu; Rüdiger Lange; Markus Krane
Journal:  Cardiovasc Res       Date:  2018-07-01       Impact factor: 10.787

Review 8.  Targeting GPCR-Gβγ-GRK2 signaling as a novel strategy for treating cardiorenal pathologies.

Authors:  Valeria Rudomanova; Burns C Blaxall
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-01-25       Impact factor: 5.187

9.  Podoplanin neutralization improves cardiac remodeling and function after acute myocardial infarction.

Authors:  Maria Cimini; Venkata Naga Srikanth Garikipati; Claudio de Lucia; Zhongjian Cheng; Chunlin Wang; May M Truongcao; Anna Maria Lucchese; Rajika Roy; Cindy Benedict; David A Goukassian; Walter J Koch; Raj Kishore
Journal:  JCI Insight       Date:  2019-07-09

10.  Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling.

Authors:  Yulin Li; Zhenya Li; Congcong Zhang; Ping Li; Yina Wu; Chunxiao Wang; Wayne Bond Lau; Xin-Liang Ma; Jie Du
Journal:  Circulation       Date:  2017-03-01       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.